Immunohistochemistry via hybridization chain reaction
The present disclosure relates to methods involving HCR reactions that involve using trigger oligos to activate probes that initiate HCR.
1. A method comprising:
providing a probe comprising a target-binding region linked to a structured nucleic acid region, wherein the structured nucleic acid region sequesters an HCR initiator;
providing a trigger oligo that is not covalently linked to a domain that directly binds the target, wherein the trigger oligo directly interacts with the structured nucleic acid region, which changes conformation to expose the HCR initiator; and
amplifying from the HCR initiator using HCR via a polymerization cascade that starts with the HCR initiator binding to an HCR hairpin that is not covalently linked to a domain that directly binds the target,
wherein when the trigger oligo binds to an input domain, it exposes an output domain which is capable of triggering HCR, wherein the structured nucleic acid region comprises a hairpin probe, and wherein the hairpin probe comprises: the input domain comprising a toehold and stem section; and the output domain comprising a hairpin loop and a complement to the stem section, such that the output domain comprises the sequestered HCR initiator.
2. The method of claim 1 , wherein HCR is performed using at least a first and second set of metastable HCR hairpin monomers.
3. The method of claim 2 , wherein the first and second set of metastable HCR hairpin monomers each further comprise a reporter molecule.
4. The method of claim 3 , wherein the reporter molecules are fluorescent molecules, non-fluorescent molecules, FRET molecules, or rare earth elements.
5. The method of claim 2 , wherein the first and second set of metastable HCR hairpin monomers each further comprise a label-binding site that is configured to hybridize to a complement to the label binding site, wherein the complement to the label binding site further comprises a reporter molecule.
6. The method of claim 1 , wherein a target molecule is a protein.
7. The method of claim 1 , wherein a target molecule is a small molecule or nucleic acid.
8. The method of claim 1 , wherein a target molecule is a complex of two or more proteins, nucleic acids, and/or small molecules.
9. The method of claim 1 , wherein the structured nucleic acid region comprises DNA, RNA, LNA, PNA, 2′OMe-RNA, or a synthetic nucleic acid analog.
10. The method of claim 1 , wherein the target-binding region comprises DNA, RNA, LNA, PNA, 2′OMe-RNA, a synthetic nucleic acid analog, amino acid, or synthetic amino acid analog.
11. The method of claim 1 , wherein the target-binding region is an antibody.
12. The method of claim 11 , wherein the antibody comprises a primary antibody.
13. The method of claim 1 , further comprising washing away any unbound probe from a sample.
14. The method of claim 13 , wherein a trigger oligo is added to the sample, after unbound probe has been washed from the sample.
15. The method of claim 1 , wherein more than one target is assayed for at a time, wherein each probe comprises a target-binding region selective for each target to be assayed for.
16. The method of claim 1 , wherein amplifying generates a detectable polymer that indicates a presence of a target molecule, wherein the target molecule is bound by the target-binding region.
17. A method comprising:
providing a probe comprising a target-binding region linked to a structured nucleic acid region, wherein the structured nucleic acid region sequesters an HCR initiator;
providing a trigger oligo containing an exposed domain that is unstructured in the absence of other nucleic acid molecules, wherein the exposed domain directly interacts with the structured nucleic acid region, which changes conformation to expose the HCR initiator; and
amplifying from the HCR initiator using HCR via a polymerization cascade that starts with the HCR initiator binding to an HCR hairpin that is not covalently linked to a domain that directly binds the target,
wherein when the trigger oligo binds to an input domain, it exposes an output domain which is capable of triggering HCR, wherein the structured nucleic acid region comprises a hairpin probe, and wherein the hairpin probe comprises: the input domain comprising a toehold and stem section; and the output domain comprising a hairpin loop and a complement to the stem section, such that the output domain comprises the sequestered HCR initiator.
18. A method comprising:
providing a probe comprising a target-binding region linked to a structured nucleic acid region, wherein the structured nucleic acid region sequesters an HCR initiator;
providing a trigger oligo that is not covalently linked to a domain that directly binds the target, wherein the trigger directly interacts with the structured nucleic acid region, which changes conformation to expose the HCR initiator; and
amplifying from the HCR initiator using HCR via a polymerization cascade that starts with the HCR initiator binding to an HCR hairpin that is not covalently linked to a domain that directly binds the target,
wherein the target-binding region is an antibody, and
wherein the antibody comprises a first antibody that binds to the target molecule, and a second antibody that binds to the first antibody, wherein the structured nucleic acid region is linked to the second antibody but is not linked to the first antibody.
19. A method comprising:
providing a probe comprising a target-binding region linked to a structured nucleic acid region, wherein the structured nucleic acid region sequesters an HCR initiator;
providing a trigger oligo containing an exposed domain that is unstructured in the absence of other nucleic acid molecules, wherein the exposed domain directly interacts with the structured nucleic acid region, which changes conformation to expose the HCR initiator; and
amplifying from the HCR initiator using HCR via a polymerization cascade that starts with the HCR initiator binding to an HCR hairpin that is not covalently linked to a domain that directly binds the target,
wherein the target-binding region is an antibody, and
wherein the antibody comprises a first antibody that binds to the target molecule, and a second antibody that binds to the first antibody, wherein the structured nucleic acid region is linked to the second antibody but is not linked to the first antibody.